US 12319916
Modulation of gene transcription using antisense oligonucleotides targeting regulatory RNAs
granted A61PA61P13/00
Quick answer
US patent 12319916 (Modulation of gene transcription using antisense oligonucleotides targeting regulatory RNAs) held by CAMP4 Therapeutics Corporation expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CAMP4 Therapeutics Corporation
- Grant date
- Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P13/00